|
ACOR
|
Acorda Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ACRX
|
AcelRx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ATHX
|
Athersys, Inc.
|
US
|
NASDAQ
|
|
BBC
|
Virtus LifeSci Biotech Clinical Trials ETF
|
US
|
AMEX
|
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
|
BXRX
|
Baudax Bio, Inc.
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EXAI
|
Exscientia Limited
|
US
|
NASDAQ
|
|
GLSI
|
Greenwich LifeSciences, Inc.
|
US
|
NASDAQ
|
|
GLYC
|
GlycoMimetics, Inc.
|
US
|
NASDAQ
|
|
HCM
|
Hutchison China MediTech Limited
|
US
|
NASDAQ
|
|
ICLR
|
ICON plc
|
US
|
NASDAQ
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
US
|
NASDAQ
|
|
LPCN
|
Lipocine Inc.
|
US
|
NASDAQ
|
|
LQDA
|
Liquidia Technologies, Inc.
|
US
|
NASDAQ
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MREO
|
Mereo BioPharma Group plc
|
US
|
NASDAQ
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
US
|
NASDAQ
|